Viewing StudyNCT06288893



Ignite Creation Date: 2024-05-06 @ 8:11 PM
Last Modification Date: 2024-10-26 @ 3:22 PM
Study NCT ID: NCT06288893
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-04
First Post: 2024-02-29

Brief Title: SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections COVID-19
Sponsor: JKT Biopharma Co Ltd
Organization: JKT Biopharma Co Ltd

Conditions & Keywords Data

Conditions:
Name
COVID-19
Keywords:
Name View
safety and pharmacokinetics View
SHEN211 tablets View
multicenter phase II clinical study View
efficacy View